KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Share-based Compensation (2016 - 2026)

CareDx's Share-based Compensation history spans 14 years, with the latest figure at $9.8 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 9.76% to $9.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $35.7 million, a 39.19% decrease, with the full-year FY2025 number at $34.9 million, down 47.5% from a year prior.
  • Share-based Compensation hit $9.8 million in Q1 2026 for CareDx, up from $8.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for CDNA hit a ceiling of $16.9 million in Q3 2024 and a floor of $8.1 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $12.2 million across 5 years, with a median of $12.1 million in 2022.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 65.76% in 2024 and later plummeted 51.0% in 2025.
  • Tracing CDNA's Share-based Compensation over 5 years: stood at $12.1 million in 2022, then dropped by 17.85% to $10.0 million in 2023, then skyrocketed by 65.76% to $16.5 million in 2024, then plummeted by 51.0% to $8.1 million in 2025, then increased by 21.16% to $9.8 million in 2026.
  • Business Quant data shows Share-based Compensation for CDNA at $9.8 million in Q1 2026, $8.1 million in Q4 2025, and $8.4 million in Q3 2025.